Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application

• Published in: Journal of ginseng research Vol. 37; no. 1; pp. 135 - 141
• Main Authors: Kim, Jung Soo, Kim, Yunjeong, Han, Song-Hee, Jeon, Ji-Young, Hwang, Minho, Im, Yong-Jin, Kim, Jung Hyun, Lee, Sun Young, Chae, Soo-Wan, Kim, Min-Gul
• Format: Journal Article
• Language: Korean
• Published: 2013
• Subjects: LC-MS/MS; Compound K; Fermented Korean red ginseng; Pharmacokinetics; Panax ginseng
• ISSN: 1226-8453; 2093-4947

A rapid, sensitive and selective analytical method was developed and validated for the determination of compound K, a major intestinal bacterial metabolite of ginsenosides in human plasma. Liquid-liquid extraction was used for sample preparation and analysis, followed by liquid chromatography tandem spectrometric analysis and an electrospray-ionization interface. Compound K was analyzed on a Phenomenex Luna C18 column ($100{\times}2.00$ mm, 3 ${\mu}m$) with the mobile phase run isocratically with 10 mM ammonium acetate-methanol-acetonitrile (5:47.5:47.5, v/v/v) at a flow rate of 0.5 mL/min. The method was validated for accuracy (relative error <12.63%), precision (coefficient of variation <9.14%), linearity, and recovery. The assay was linear over the entire range of calibration standards i.e., a concentration range of 1 ng/mL to 1,000 ng/mL ($r^2$ >0.9968). The recoveries of compound K after liquid-liquid extraction at 1, 2, 400, and 800 ng/mL were $106.00{\pm}0.08%$, $103.50{\pm}0.19%$, $111.45{\pm}5.21%$, and $89.62{\pm}34.46%$ for intra-day and $85.40{\pm}0.08%$, $94.50{\pm}0.09%$, $112.50{\pm}5.21%$, and $95.87{\pm}34.46%$ for inter-day, respectively. The lower limit of quantification of the analytical method of compound K was 1 ng/mL in human plasma. The developed method was successfully applied to a pharmacokinetic study of compound K after oral administration in ten of healthy human subjects.